| SECTOR | INDUSTRY |
| Consumer Staples | Personal Care Products |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | BFNH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $129.8 | $250.9 | 24% |
|
| Shares Out (Mil) | 33.5 | 27.3 | 39% |
|
| Institutional Ownership | na | 50.0% | na |
|
| Float (Mil) | na | 33.2 | na |
|
| Beta | na | 0.64 | na |
|
| Avg Daily Volume (000s) | 10 | 147 | 17% |
|
| Price Change (52-week) |
137.4% | 55.2% | 94% |
|
| Growth | BFNH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 1.8% | na |
|
| Net Income (5yr) | 61.7% | (4.8%) | 96% |
|
| EPS (5yr) | 66.8% | 2.3% | 97 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | 0.0% | (14.9%) | 64% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BFNH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $417 | na |
|
| Net Income (TTM) (Mil) | $-0 | ($5) | 39% |
|
| EPS (TTM) | ($0.003) | ($0.100) | 39% |
|
| Operating Cash Flow (TTM) (Mil) | $0 | $16 | 32% |
|
| Net Cash Flow (TTM) (Mil) | na | $3 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $43 | 0% |
|
| Enterprise Value (Q1) (Mil) | $81 | $302 | 20% |
|
| Valuation | BFNH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 55.29 | 1.66 | 99% |
|
| P/E | na | 15.5 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.6 | na |
|
| Ratios | BFNH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 64.2% | na |
|
| Net Margin | na | 1.2% | na |
|
| ROA | (8.2%) | (1.5%) | 27% |
|
| ROE | (10.2%) | 1.0% | 28% |
|
| Liabilities to Assets | 3.5% | 48.8% | 1% |
|
| F-Score | 3 | 4 | 18% |
|
BioForce Nanosciences Holdings, Inc. did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
